Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • epistatic
    Senior Member
    • Mar 2009
    • 129

    #1

    HiSeq 2500 run, not hopeful on a quality PE-150 quick run

    The data set from the quick run mode on the HS2500 posted isn't too hopeful to have the proposed MiSeq run quality with a shorter run. Is it still spec'd to run PE-150 at a decent % >Q30?



    >= Q30 90.2% 123.7G
    R1 92.9% 63.7G
    R2 87.5% 60.0G

    Last edited by epistatic; 10-09-2012, 02:24 PM.
  • GenoMax
    Senior Member
    • Feb 2008
    • 7142

    #2
    There is probably an inherent assumption that you are willing to sacrifice quality to some extent to get the rapid turnaround.

    MiSeq (in specific instances, e.g. 16S multiplexed libraries) is showing similar problems with declining quality in later cycles for 2 x 250 cycle runs.

    Comment

    • epistatic
      Senior Member
      • Mar 2009
      • 129

      #3
      I am glad I was skeptical when I was told our HiSeq 2500 upgrade would allow >= 80% Q30 on PE-150 runs in the fast run mode and to expect >= 95% Q30 for PE-100. I was hoping to run TSCAP 250 bp capture panels on the HS2500 with PE-150.

      We are still very anxious to get the upgrade for quick run times and the ability to run 2 lane flow cells.

      Comment

      Latest Articles

      Collapse

      • SEQadmin2
        16S/ITS Profiling vs. Shotgun Metagenomics: What Changes in Your Workflow?
        by SEQadmin2




        NGS has revolutionized clinical microbiology by offering new ways to identify and surveil pathogens without prior knowledge of the target. One popular approach is 16S rRNA and ITS amplicon sequencing, which targets specific microbial markers. But studies are increasingly incorporating shotgun metagenomics, a technique that sequences all DNA from a sample without targeting specific microbial markers. This approach allows more detailed taxonomic classification, detection...
        Today, 06:46 AM
      • SEQadmin2
        Multiomic Liquid Biopsy: What DNA/RNA Panels Reveal That DNA Alone Can’t
        by SEQadmin2



        Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?

        Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating
        ...
        10-14-2026, 09:55 AM

      ad_right_rmr

      Collapse

      News

      Collapse

      Topics Statistics Last Post
      Started by SEQadmin2, 10-28-2026, 09:57 AM
      0 responses
      22 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 10-28-2026, 09:51 AM
      0 responses
      14 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 10-22-2026, 11:13 AM
      0 responses
      67 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 10-22-2026, 10:48 AM
      0 responses
      47 views
      0 reactions
      Last Post SEQadmin2  
      Working...